Clinical significance and time course of antibodies to glutamic acid decarboxylase in Japanese children with type I (insulin-dependent) diabetes mellitus

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 5, 1996, Pages 558-563

  Sugihara, S ^a   Konda, S ^a   Wataki, K ^a   Kobayashi, Y ^a   Murata, A ^a   Miyamoto, S ^b   Kubo, H ^c   Yamaguchi, A ^c   Sasaki, N ^d   Niimi, H ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA CHILDREN'S HOSPITAL   (Japan)

^c SANOFI   (France)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti glutamic acid decarboxylase antibodies; Insulin dependent diabetes mellitus

Indexed keywords

ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE; MARKER;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEX DIFFERENCE;

EID: 9044249329     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14086.x     Document Type: Article

References (27)

1. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64k autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151-6
2. Rowley MJ, Mackay IR, Chen Q-Y, Knowles WJ, Zimmet P. Antibodies toglutamic acid decarboxylase discriminate major type of diabetes mellitus. Diabetes 1992;41:548-51
3. Thivolet CH, Tappaz M, Durand A, Petersen J, Stefanutti A, Chatelain P, et al. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of Type 1 (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia 1992;35:570-6
4. Serjeantson SW, Kohonen-Corish MRJ, Rowley MJ, Mackay IR, Knowles W, Zimmet P. Antibodies to glutamic acid decarboxylase are associated with HLA-DR genotypes in both Australians and Asians with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992;35:996-1001
5. Zimmett PZ, Rowley MJ, Mackay IR, Knowles WJ, Chen QY, Chapman LH, et al. The ethnic distribution of antibodies to glutamic acid decarboxylase: presence and levels in insulin-dependent diabetes mellitus in European and Asian subjects. J Diabetic Complications 1993;7:1-7
6. Seissler J, Amann J, Mauch L, Haubruck H, Wolfahrt S, Bieg S, et al. Prevalence of autoanlibodies to 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1993;92:1394-9
7. De Aizpurua HJ, Wilson YM, Harrison LC. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes. Proc Natl Acad Sci USA 1992;89:9841-5
8. Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M, Grubin CE, Sundkvist G, et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positively at onset predicts diabetes type. J Clin Invest 1993;91:368-74
9. Velloso LA, Kampe Q, Hallberg A, Christmanson L, Betsholtz C, Karlsson FA. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J Clin Inv 1993;91:2084-90
10. Chen Q-Y, Rowley MJ, Byrne GC, Jones TW, Tuomi T, Knowles WJ, et al. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives. Pediatr Res 1993;34:785-90
11. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, et al. Detection of GAD 65 antibodies in diabetes and other autoimmune disease using a simple radioligand assay. Diabetes 1994;43:459-67
12. Schmidli RS, DeAizpurua HJ, Harrison LC, Colman PG. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex, and islet cell antibody status, and temporal profile. J Autoimmunity 1994;7:55-66
13. Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Toivanen L, et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 1994;343:1383-5
14. WHO Study Group. Definition, diagnosis, and classification. Technical report series 727. Geneva: World Health Organization 1985:9-20
15. Wu JY, Denner L, Lin CT, Song G. L-Glutamine decarboxylase from brain. Methods Enzymol 1985;113:3-17
16. Gottlieb DI, Chang YC, Schwob JE. Monoclonal antibodies to glutamic acid decarboxylase. Proc Natl Acad Sci USA 1986; 83:8808-12
17. Yamaguchi A, Ogata K, Kubo H, Ohta K, Mizushima Y, Ishige H, et al. Performance and characteristic study of "RIP Anti-GAD Hoechst" RIA kit in detection of anti-GAD antibodies. Med Pharmacol 1994;31:419-31
18. Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Takao Y, et al. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 1994; 43:80-6
19. Matsuba I, Tsuruoka A, Kawasaki E, Toyota T, Ishiki G, Nagataki S, et al. Anti-GAD AB in IDDM, NIDDM and normal controls: Cooperative study by 15 Japanese centers. Practice 1994;11:274-8
20. Karvonen M, Tuomilehto J, Libman I, LaPorte R (for the World Health Organization DIAMOND Project Group). A review of the recent epidemiological data on the worldwide incidence of Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993;36: 883-92
21. Thorsby E, Ronningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36:371-7
22. Schmidli RS, Colman PG, Bonifacio E, Bottazzo GF, Harrison LC, participating laboratories. High level of concordance between assays for glutamic acid decarboxylase antibodies. The First International Glutamic Acid Decarboxylase Antibody Workshop. Diabetes 1994;43:1005-9
23. Schmidli RS, Colman PG, Bonifacio E, participating laboratories. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International GADAb Workshop. Diabetes 1995;44:636-40
24. Kaufman DL, Erlander MG, Clare-Salzier M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992;89:283-92
25. Mosmann TR, Coffman RL. Two types of mouse helper T cell clone: implications for immune regulation. Immunol Today 1987;8:223-7
26. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989;46: 111-47
27. Scott P, Kaufman SHE. The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 1991;12:346-8